Miro, Elizabeth .

HRN: 09-06-82  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2024
CEFOTAXIME 500MG (VIAL)
07/10/2024
07/16/2024
PO
500mg
BId
Thinly MSAF
Waiting Final Action 
07/10/2024
CEFUROXIME 500MG (TAB)
07/10/2024
07/16/2024
PO
500mg
Bid
Thinly Msaf
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: